As the market opens for a new trading day, here are some stocks that are in focus. From BHEL’s new contract to Glenmark Pharma’s earnings update, several companies are in news today.
Here is a look at the list of stocks in news today, February 17.
Market recap
The Indian stock market ended last week on a weak note, marking its eighth straight session in the red. On Friday, the BSE Sensex fell 199.76 points to close at 75,939.21 after briefly plunging nearly 700 points during the day. The NSE Nifty 50 also slipped 102.15 points, settling at 22,929.25.
Stocks to watch on February 17, 2025
BHEL
The government-owned engineering company has won a huge Rs 6,700 crore contract from Singareni Collieries Company (SCCL) to build an 800 MW thermal power unit in Telangana. The project includes everything from design to final commissioning.
In the previous trading session, BHEL share price closed at Rs 192.93, down 4.40%.
MTNL
The state-run telecom company reported a net loss of Rs 836 crore in Q3FY25, almost the same as last year’s Rs 839 crore loss. Revenue dropped 11.6% to Rs 170 crore, highlighting ongoing challenges in the telecom sector.
MTNL share price closed at Rs 46.40 per share in the previous trading session, falling 6.26%.
Zen Technologies
The defence tech firm has invested in Vector Technics and Bhairav Robotics, expanding beyond combat training into advanced defence solutions. Zen Technologies’ share price dropped 7.26% on Monday, closing at Rs 1,345.40.
Zydus Lifesciences
The pharmaceutical company successfully completed a US FDA inspection at its Ambernath, Maharashtra, manufacturing facility with no issues found, a positive sign for regulatory compliance.
Zydus Lifesciences share price declined 4.62% to Rs 899.30 in the previous trading session.
Wipro
Wipro has appointed Amit Kumar as Managing Partner and Global Head of Wipro Consulting. He will report directly to CEO Srini Pallia and join the company’s Executive Board.
Alembic Pharma
Alembic Pharmaceuticals received a Voluntary Action Indicated (VAI) classification from the US FDA for its solid oral formulation facility in Jarod. The inspection took place in November 2024.
RVNL
The railway infrastructure firm reported a 13.1% drop in net profit to Rs 311.6 crore for Q3FY25. Revenue also slipped 2.6% to Rs 4,567.4 crore, while EBITDA fell 3.9% to Rs 239.4 crore.
Rail Vikas Nigam share price closed at Rs 358.15 in the last trading session, slipping 5.58%.
Dr Agarwal’s Health Care
The healthcare company saw strong revenue growth of 29.5% YoY in Q3FY25, reaching Rs 431 crore. Revenue from Indian operations jumped 34.5% to Rs 390 crore, while net profit rose 25% to Rs 28 crore.
Shriram Finance
The RBI has fined Shriram Finance Rs 5.80 lakh for not complying with key banking regulations, including KYC guidelines and credit reporting rules. The company failed to follow risk categorization and reporting requirements.
Share price of Shriram Finance fell 2.21% to Rs 536.55 in the previous trading session.
Glenmark Pharma
The pharmaceutical company made a strong comeback, posting a net profit of Rs 347.9 crore in Q3FY25 after a loss of Rs 351.3 crore last year. Revenue surged 35.1% YoY to Rs 3,387.6 crore, and EBITDA rebounded to Rs 600.3 crore. Zen Technologies.